Philip Li

Philip Li is an accomplished professional in the field of medical communications, currently serving as Associate Director at Novocure since January 2022. Previously, Philip held the position of Associate Director of Scientific Communications and Medical Scientist at Ferring Pharmaceuticals from March 2017 to January 2022. Additionally, Philip worked at Syneos Health as Editorial Group Director and Medical Education Consultant from November 2010 to March 2017. Earlier roles include Principal Medical Writer, Senior Medical Writer, and Medical Writer at Medicus International from March 2006 to November 2010, and Postdoctoral Research Fellow at University College London from March 2004 to March 2006. Philip's educational background includes a PhD in Neuroendocrinology from the University of Bristol, a Master of Science in Human Molecular Genetics from Imperial College London, and a Bachelor of Science in Medical Biochemistry from King's College London.